Tag Archives: false advertising

unexplained “3x more cutting power” could be false advertising when comparator was unexpected

Fiskars Finland OY AB v. Woodland Tools Inc., No. 22-cv-540-jdp, 2024 WL 3936444 (W.D. Wis. Aug. 26, 2024) The parties compete in the hand-held gardening tool market. Most of the claims failed on summary judgment, but part of Woodland’s claim … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

using results from one product to tout another isn’t passing off, but could be false advertising

Ortho-Tain, Inc. v. Colorado Vivos Therapeutics, Inc., 2024 WL 3925408, No. 20 C 4301 (N.D. Ill. Aug. 23, 2024) Ortho-Tain sued defendants (including a bunch of former employees); I’ll focus only on the Lanham Act claims alleging that they falsely … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Vizzy gets no kick from champagne, and that’s ok

West v. Molson Coors Beverage Co. USA, No. 23-cv-7547 (BMC), 2024 WL 3718613 (E.D.N.Y. Aug. 7. 2024) Plaintiffs alleged that Molson deceived consumers into thinking that Vizzy contained champagne (used as a generic term throughout!) when it didn’t. The court … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

9th Circuit orders district court to reconsider statutory damages award to NY class under NY law

Montera v. Premier Nutrition Corporation, — F.4th —-, 2024 WL 3659589, No. 22-16375, 22-16622 (9th Cir. Aug. 6, 2024) The key legal issue here arises from the quirk that NY bans GBL §§ 349 and 350 class actions in state … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

FDCA doesn’t preclude lawsuit based on allegedly false claims about compounding drugs

Pacira Biosciences, Inc. v. Nephron Sterile Compounding Center, LLC, No. 3:23-5552-CMC, 2024 WL 3656489 (D.S.C. Jul. 15, 2024) Pacira, which sells non-opioid pain management products, including Exparel, sued Nephron for false advertising. Exparel is “bupivacaine suspended in multivesicular liposomes,” and … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Lanham Act unclean hands defenses are hard to win

World Nutrition Inc. v. Advanced Enzymes USA, No. CV-19-00265-PHX-GMS, 2024 WL 3665360 (D. Ariz. Aug. 6, 2024) The parties—here WNI and AST—sell enzyme supplements and sued each other under the Lanham Act, and both prevailed on their affirmative claims and … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Court accepts survey with disclaimer control that causes 38% confusion

 Another ruling in the PNC v. Plaid case: PNC Financial Services Gp. v. Plaid Inc., 2024 WL 3691607, No. 2:20-cv-1977 (W.D. Pa. Aug. 7, 2024) Daubert motions for this case. I’ll only discuss the stuff I find interesting.   Kivetz … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Plaid must face jury on PNC’s TM/advertising claims, but has good laches/acquiescence argument

PNC Financial Services Gp. v. Plaid Inc., 2024 WL 3687956, No. 2:20-cv-1977 (W.D. Pa. Aug. 7, 2024) PNC is “a large, diversified financial institution offering retail and wholesale banking services,” while Plaid connects cash payment and investment account applications like … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

State Little FTC Acts still have teeth, as Georgia’s proves

Federal Trade Commission v. Peyroux, — F.Supp.3d —-, 2024 WL 1283344, No. 1:21-cv-3329-AT (N.D. Ga. Mar. 11, 2024) The FTC and the state of Georgia sued three corporate defendants and two individual defendants, Peyroux and Detelich. The underlying acts carried … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Grubhub’s listing of unaffiliated restaurants on its platform could infringe TM

Lynn Scott, LLC v. Grubhub Inc., 2024 WL 3673718, No. 20 C 6334 (N.D. Ill. Aug. 6, 2024) Restaurants brought a putative class action alleging that Grubhub used their names and logos confusingly, asserting claims under the Lanham Act. “Grubhub … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment